These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26474244)

  • 1. A novel antiamoebic agent against Acanthamoeba sp.--A causative agent for eye keratitis infection.
    Kusrini E; Hashim F; Azmi WN; Amin NM; Estuningtyas A
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 153():714-21. PubMed ID: 26474244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-amoebic activity of acyclic and cyclic-samarium complexes on Acanthamoeba.
    Kusrini E; Hashim F; Gunawan C; Mann R; Azmi WNNWN; Amin NM
    Parasitol Res; 2018 May; 117(5):1409-1417. PubMed ID: 29532220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
    Mrva M; Garajová M; Lukáč M; Ondriska F
    J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of In Vitro Antiamoebic Activity of Antimicrobial Agents Against Clinical Acanthamoeba Isolates.
    Nakaminami H; Tanuma K; Enomoto K; Yoshimura Y; Onuki T; Nihonyanagi S; Hamada Y; Noguchi N
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):629-634. PubMed ID: 28704121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy inhibitors as a potential antiamoebic treatment for Acanthamoeba keratitis.
    Moon EK; Kim SH; Hong Y; Chung DI; Goo YK; Kong HH
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4020-5. PubMed ID: 25896709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba.
    Padzik M; Hendiger EB; Chomicz L; Grodzik M; Szmidt M; Grobelny J; Lorenzo-Morales J
    Parasitol Res; 2018 Nov; 117(11):3519-3525. PubMed ID: 30112674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro development of an effective treatment for Acanthamoeba keratitis.
    Ortillés Á; Belloc J; Rubio E; Fernández MT; Benito M; Cristóbal JÁ; Calvo B; Goñi P
    Int J Antimicrob Agents; 2017 Sep; 50(3):325-333. PubMed ID: 28709990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of propolis in experimental Acanthamoeba keratitis.
    Vural A; Polat ZA; Topalkara A; Toker MI; Erdogan H; Arici MK; Cetin A
    Clin Exp Ophthalmol; 2007 Nov; 35(8):749-54. PubMed ID: 17997780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-amoebic properties of a Malaysian marine sponge Aaptos sp. on Acanthamoeba castellanii.
    Nakisah MA; Ida Muryany MY; Fatimah H; Nor Fadilah R; Zalilawati MR; Khamsah S; Habsah M
    World J Microbiol Biotechnol; 2012 Mar; 28(3):1237-44. PubMed ID: 22805843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and antiamoebic activity of dysprosium-based nanoparticles using contact lenses as carriers against Acanthamoeba sp.
    Kusrini E; Sabira K; Hashim F; Abdullah NA; Usman A; Putra N; Prasetyanto EA
    Acta Ophthalmol; 2021 Mar; 99(2):e178-e188. PubMed ID: 32701190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro study of propamidine isethionate: value in the follow-up of Acanthamoeba amebic keratitis].
    Paniagua-Crespo E; Hasle DP; Aouizerate F; Volant A; Simitzis-Le Flohic AM
    J Fr Ophtalmol; 1989; 12(6-7):489-91. PubMed ID: 2636245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of N-acyl quinolin-2(1H)-ones as new selective agents against clinical isolates of Acanthamoeba keratitis.
    Reyes-Batlle M; Freijo MB; López-Arencibia A; Lorenzo-Morales J; McNaughton-Smith G; Piñero JE; Abad-Grillo T
    Bioorg Chem; 2020 Jun; 99():103791. PubMed ID: 32247111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.
    Carrijo-Carvalho LC; Sant'ana VP; Foronda AS; de Freitas D; de Souza Carvalho FR
    Surv Ophthalmol; 2017; 62(2):203-218. PubMed ID: 27836717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient therapeutic effect of Nigella sativa aqueous extract and chitosan nanoparticles against experimentally induced Acanthamoeba keratitis.
    Elkadery AAS; Elsherif EA; Ezz Eldin HM; Fahmy IAF; Mohammad OS
    Parasitol Res; 2019 Aug; 118(8):2443-2454. PubMed ID: 31144032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga.
    Heredero-Bermejo I; Copa-Patiño JL; Soliveri J; Fuentes-Paniagua E; de la Mata FJ; Gomez R; Perez-Serrano J
    Parasitol Res; 2015 Feb; 114(2):473-86. PubMed ID: 25358240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impression cytology in the diagnosis of acanthamoeba keratitis with surface involvement.
    Sawada Y; Yuan C; Huang AJ
    Am J Ophthalmol; 2004 Feb; 137(2):323-8. PubMed ID: 14962424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp.
    Polat ZA; Karakus G
    Parasitol Res; 2013 Feb; 112(2):529-33. PubMed ID: 23052789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
    Kowalski RP; Abdel Aziz S; Romanowski EG; Shanks RM; Nau AC; Raju LV
    JAMA Ophthalmol; 2013 Nov; 131(11):1459-62. PubMed ID: 24077460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of anti-acanthamoebic approaches.
    Mungroo MR; Tong T; Khan NA; Anuar TS; Maciver SK; Siddiqui R
    Int Microbiol; 2021 Aug; 24(3):363-371. PubMed ID: 33754231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.